Nexis
RM400.00
Tirzepatide is a dual incretin receptor agonist that enhances insulin sensitivity, reduces appetite, and supports significant fat loss. It improves glycemic control while promoting sustainable weight reduction, making it a cornerstone of modern metabolic programs.
Cold-chain shipping will be arranged within 2–3 business days after payment verification. Delivery is expected within 7–9 days.